Segment Reporting (Tables)

9 Months Ended

Sep. 30, 2024

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the three and nine-month periods ended September 30, 2024 and 2023, were as follows (in thousands):

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2024		2023		2024		2023
Net sales
Cardiovascular	$	322,855	$	306,084	$	964,044	$	905,335
Endoscopy		16,990		9,146		37,312		27,516
Total net sales		339,845		315,230		1,001,356		932,851
Income from operations
Cardiovascular		37,555		32,622		113,374		82,966
Endoscopy		(294)		2,515		5,755		7,366
Total income from operations		37,261		35,137		119,129		90,332
Total other expense — net		(604)		(4,915)		(2,281)		(9,710)
Income tax expense		8,213		4,388		24,438		13,840
Net income	$	28,444	$	25,834	$	92,410	$	66,782